University of Exeter
Browse

Evaluation of Evidence for Pathogenicity Demonstrates that BLK, KLF11 and PAX4 Should not be Included in Diagnostic Testing for MODY

journal contribution
posted on 2025-08-01, 14:09 authored by TW Laver, MN Wakeling, O Knox, K Colclough, CF Wright, S Ellard, AT Hattersley, MN Weedon, KA Patel
Maturity Onset Diabetes of the Young (MODY) is an autosomal dominant form of monogenic diabetes, reported to be caused by variants in 16 genes. Concern has been raised about whether variants in BLK (MODY11), KLF11 (MODY7) and PAX4 (MODY9) cause MODY. We examined variant-level genetic evidence (co-segregation with diabetes and frequency in population) for published putative pathogenic variants in these genes and used burden testing to test gene-level evidence in a MODY cohort (n=1227) compared to population control (UK Biobank, n=185,898). For comparison we analysed well-established causes of MODY, HNF1A and HNF4A. The published variants in BLK, KLF11 and PAX4 showed poor co-segregation with diabetes (combined LOD scores ≤1.2), compared to HNF1A and HNF4A (LOD scores >9), and are all too common to cause MODY (minor allele frequency >4.95x10-5). Ultra-rare missense and protein-truncating variants (PTVs) were not enriched in a MODY cohort compared to the UK Biobank (PTVs P>0.05, missense P>0.1 for all three genes) while HNF1A and HNF4A were enriched (P<10-6). Sensitivity analyses using different population cohorts supported our results. Variant and gene-level genetic evidence does not support BLK, KLF11 or PAX4 as causes of MODY. They should not be included in MODY diagnostic genetic testing.

Funding

19/0005994

219606/Z/19/Z

Diabetes UK

MR/T00200X/1

Medical Research Council (MRC)

Research England

WT098395/Z/12/Z

Wellcome Trust

History

Related Materials

Rights

© 2022 by the American Diabetes Association. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission

Notes

This is the author accepted manuscript. The final version is available from the American Diabetes Association via the DOI in this record Data and Resource Availability: UK Biobank data is accessible via application: https://www.ukbiobank.ac.uk/enable-yourresearch. GnomAD data is publically available: https://gnomad.broadinstitute.org/. The MODY cohort data is not publicly available due the limitations of the current ethics and to protect patient confidentiality but is available from the corresponding authors on reasonable request. No applicable resources were generated or analyzed during the current study.

Journal

Diabetes

Publisher

American Diabetes Association

Place published

United States

Version

  • Accepted Manuscript

Language

en

FCD date

2022-03-22T08:52:31Z

FOA date

2022-03-24T09:46:47Z

Citation

Published online 2 February 2022

Department

  • Archive

Usage metrics

    University of Exeter

    Categories

    No categories selected

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC